Cargando…
Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target
Lung and breast cancer are the leading causes of mortality in women worldwide. The discovery of molecular alterations that underlie these two cancers and corresponding drugs has contributed to precision medicine. We found that CCND2 is a common target in lung and breast cancer. Hypermethylation of t...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213171/ https://www.ncbi.nlm.nih.gov/pubmed/30308939 http://dx.doi.org/10.3390/ijms19103096 |